XML 106 R10.htm IDEA: XBRL DOCUMENT

Restructuring

12 Months Ended

Dec. 31, 2011

3. Restructuring

The Company has incurred costs from restructuring activities related to the October 15, 2010 acquisition of Abraxis. Restructuring costs include employee termination costs, contract termination fees and facility closing costs. Employee termination costs are generally recorded when the actions are probable and estimable and include accrued severance benefits and health insurance continuation, many of which may be paid out during periods after termination of employment.

The following table summarizes the restructuring expenses and changes in the restructuring liability related to the Abraxis acquisition during 2011:

	Balance December 31, 2010		Expense Recognized		Payments		Balance December 31, 2011		Cumulative Payments

Employee termination benefits	$	14,881	$	2,312	$	13,383	$	3,810	$	14,616
Contract termination fees		-		1,304		1,304		-		1,304
Facility closing costs		-		1,858		1,154		704		1,154

Total restructuring costs	$	14,881	$	5,474	$	15,841	$	4,514	$	17,074

Restructuring expenses of $16.1 million related to employee termination benefits were recognized during 2010. The Company does not expect to incur material additional restructuring expenses related to the acquisition of Abraxis. Future cash payments related to the restructuring activity are estimated to be approximately $2.7 million in 2012 and $1.8 million in 2013.

- Definition

The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.

+ References+ Details